TP53 and neoplasm: Use of TG2 specific inhibitor GK921 and streptonigrin as monotherapeutic strategy in RCC mouse xenograft models showed a strong anti-tumor effect by stabilizing the cellular p53 levels and inducing apoptosis [93].